7.07% -0.0179

Dopo l'orario di chiusura: .22 -0.0154 -6.54%

Theriva Biologics Inc (TOVX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Theriva Biologics Inc Borsa (TOVX) Ultime notizie

Theriva Biologics Inc (TOVX)

Theriva Biologics Inc Borsa (TOVX) Ultime notizie

Theriva Biologics (TOVX) Secures Approval for VIRAGE2 Clinical T - GuruFocus

Theriva Biologics launches VIRAGE2 metastatic pancreatic trial - TipRanks

Theriva Biologics cleared to start VIRAGE2 trial | TOVX 8-K Filing - Stock Titan

Theriva Biologics receives approval to start VIRAGE2 cancer trial By Investing.com - Investing.com Canada

Theriva wins Spain nod for more frequent VCN-01 dosing in pancreatic cancer trial - Stock Titan

Theriva Biologics (TOVX) Holds Steady Near Support After Modest GainRetracement Entry - dars.gov.et

Form DEF 14A THERIVA BIOLOGICS For: 29 June By Investing.com - Investing.com Nigeria

Theriva Biologics (NYSE American: TOVX) puts large share and warrant proposals to vote - Stock Titan

Enterprise value to EBIT forward of Theriva Biologics, Inc. – AMEX:TOVX - TradingView

Price to book forward of Theriva Biologics, Inc. – AMEX:TOVX - TradingView

Enterprise value to EBIT forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView

Enterprise value to EBITDA forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView

Enterprise value to revenue forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView

Price to sales forward of Theriva Biologics, Inc. – AMEX:TOVX - TradingView

Price to earnings forward of Theriva Biologics, Inc. – FWB:SFY0 - TradingView

Theriva Biologics Company Profile & Introduction - Moomoo

Theriva Biologics, Inc. Actuals & Estimates (AMEX:TOVX) - TradingView

TOVX Forecast — Price Target — Prediction for 2027 - TradingView

Theriva Biologics, Inc. Actuals & Estimates (FWB:SFY0) - TradingView

SFY0 Forecast — Price Target — Prediction for 2027 - TradingView

Theriva Biologics Inc (TOVX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Theriva Biologics (TOVX) Proxy filing Summary - Quartr

Theriva Biologics Inc (TOVX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

TOVX Should I Buy - Intellectia AI

Theriva Biologics Inc (TOVX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Theriva Biologics Inc (TOVX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Theriva Biologics (TOVX) asks shareholders to approve share, plan and warrant changes - Stock Titan

Theriva Biologics Inc (TOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Theriva Biologics Inc (TOVX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Theriva Biologics Inc (TOVX) Institutional Confidence - TradingKey

Theriva Biologics Inc (TOVX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Theriva Biologics Inc (TOVX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Why is Theriva stock gaining Monday? - MSN

Theriva Biologics (TOVX) Surges Over 26%: Key Levels to Watch After BreakoutCall Resistance - newsline.com

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention - TechStock²

Theriva Biologics reports survival data from VCN-01 cancer trial - Investing.com

Theriva Biologics highlights promising VCN-01 Phase 1 results - TipRanks

$Theriva Biologics (TOVX.US)$ - Moomoo

Theriva Biologics (NYSE American: TOVX) shares VCN-01 Phase 1 head and neck cancer data - Stock Titan

Small trial: virus-immunotherapy combo linked to longer survival in head and neck cancer - Stock Titan

TOVX Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline AdvancesOperating Margin Analysis - newsline.com

Theriva Biologics Faces Quorum Issue Delaying Warrant Vote - TipRanks

Theriva Biologics (NYSE: TOVX) fails quorum, delays 16.18M-warrant share vote - Stock Titan

MSN Money - MSN

Number of shareholders of Theriva Biologics, Inc. – AMEX:TOVX - TradingView

Theriva Biologics (TOVX) Slides 8% as Stock Tests Key Support at $0.27Dark Pool Sentiment - The Legal Advocate

Theriva Biologics (TOVX) Faces Pressure: Stock Slides 8% as Key Support Levels Are TestedLeveraged ETF Flow - The Legal Advocate

Theriva Biologics (TOVX) Advances 4.99% as Stock Approaches Key Resistance at $0.33McClellan Oscillator - newsline.com

Theriva Biologics (TOVX) Gains Nearly 5% as Stock Attempts to Recover Key Support LevelsAI Trade Signals - The Legal Advocate

TOVXTheriva Biologics Inc Stock Price and Quote - Finviz

Theriva Biologics (TOVX) Slides 5.73% as Price Nears Critical Support at $0.28BPI Reversal - The Legal Advocate

Theriva Biologics (TOVX) Q1 2026 Earnings: Slight EPS Beat Boosts Sentiment for Clinical-Stage BiotechMargin Guidance - The Legal Advocate

Theriva Biologics (TOVX) Q1 2026 Earnings: Narrowed Loss Beats Expectations as Stock RisesBanking Earnings Report - Newser

Theriva Biologics (TOVX) Dips 1% as Stock Hovers Near Key Support at $0.28Value Area Low - Newser

Theriva Biologics (TOVX) Hovers Near Support After Modest DeclineCommunity Breakout Alerts - Newser

Theriva Biologics (TOVX) Delivers Q1 2026 Beat — EPS $-0.05 vs $-0.05 ExpectedShared Trade Ideas - Newser

Theriva Biologics (TOVX) Declines -9.35% Amid Market Weakness 2026-05-17Top Analyst Buy Signals - Newser

Simile a TOVX